Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$2,756,290
+$634,381 QoQ
Shares Held
2,298
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.33%
of 13F equity value
Holder Rank
#2,203
of 4,605 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026William B. Walkup & Associates, Inc. holds $17,485,961 across 7 Drug Manufacturers - General names. LLY ranks #4 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
25,392 | $6,389,642 | |
| 2 | MRK |
Merck & Co., Inc.
|
27,033 | $3,473,740 | |
| 3 | JNJ |
Johnson & Johnson
|
12,858 | $3,265,546 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
2,298 | $2,756,290 | |
| 5 | PFE |
Pfizer Inc
|
49,061 | $1,181,388 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,074 | $407,603 | |
| 7 | OGN |
Organon & Co.
|
868 | $11,752 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,756,290 | 2,298 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,121,909 | 2,307 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,479,286 | 2,307 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,760,241 | 2,307 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,798,375 | 2,307 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,905,374 | 2,307 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,775,600 | 2,300 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,037,662 | 2,300 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $2,114,062 | 2,335 | Shares | Sole | 2024-08-16 | |
| No filing history on record for this holder in this stock. | ||||||